Capital Performance Advisors »

Zentalis Pharmaceuticals shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $287 78 3.68

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
BlackRock
Vanguard Group
Citadel Advisors
Decheng Capital
Opaleye Management
Morgan Stanley
Almitas Capital
PRIMECAP Management Company
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Verition Fund Management
MPM Oncology Impact Management

View all funds holding Zentalis Pharmaceuticals